skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
p53 Peptide Vaccine (Code C1986)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: p53 Peptide Vaccine

Definition: A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein. (NCI04)

Label: p53 Peptide Vaccine

NCI Thesaurus Code: C1986 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0879339  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
p53:264-272 Peptide
p53 Peptide Vaccine

External Source Codes: 
NSC Code 717111 (see NCI DTP info)
PDQ Closed Trial Search ID 43633
PDQ Open Trial Search ID 43633 (check for NCI PDQ open clinical trial info)
UMLS CUI C0879339

Other Properties:
     Name Value (qualifiers indented underneath)
code C1986
Legacy_Concept_Name p53_Peptide_Vaccine
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom